Arab Board Pediatrics Final Written study materials
Arab Board Pediatrics Final Written study resources

A 3-week-old with worsening jaundice and poor feeding

Arab Board Pediatrics Final Written · Put your knowledge to work in context.

All case studies

A 3-week-old with worsening jaundice and poor feeding

A 3-week-old boy, born at 38 weeks by spontaneous vaginal delivery, birth weight 3.1 kg, is brought to the emergency department with 2 days of poor feeding and increasing lethargy. He was discharged at 48 hours with a bilirubin of 9 mg/dL and follow-up arranged. The family missed the 1-week visit because they were travelling. Today he weighs 2.7 kg. He is jaundiced to the abdomen, has a weak suck, and has passed pale stools for the last 5 days (parents thought this was normal). Temperature 36.8 C, HR 150, RR 50, capillary refill 4 seconds. Bedside glucose is 2.1 mmol/L. Total bilirubin is 19 mg/dL with a direct fraction of 8 mg/dL. The mother's blood group is O positive; the baby is A positive.

1. What is the most likely unifying diagnosis, and what findings in the history and examination point toward it rather than toward breast-milk jaundice or ABO haemolytic disease?

Read the worked answer

The unifying diagnosis is biliary atresia (with secondary cholestasis and fat-soluble vitamin malabsorption), presenting as a conjugated hyperbilirubinaemia in a 3-week-old.

Key features that point away from breast-milk jaundice:

  • Breast-milk jaundice is unconjugated; here the direct fraction is 8 of 19 mg/dL (≈42%), well above the 20% / 2 mg/dL threshold that defines conjugated hyperbilirubinaemia in a neonate.
  • Pale, acholic stools for 5 days - breast-milk jaundice does not cause this.
  • Weight loss from 3.1 to 2.7 kg (≈13%) indicates inadequate intake but does not explain the direct fraction.

Key features that point away from ABO haemolytic disease:

  • ABO disease causes unconjugated hyperbilirubinaemia, typically peaking in the first 3–5 days, not at 3 weeks.
  • The mother is O and baby A, so ABO is possible, but the direct fraction and pale stools are not consistent with it.

Other causes to keep in mind (and how they would look different):

  • Neonatal hepatitis / TORCH / metabolic (galactosaemia, tyrosinaemia): would usually show hepatomegaly, poor weight gain, and often other systemic signs; galactosaemia would have reducing substances and E. coli sepsis risk.
  • Choledochal cyst: would be seen on ultrasound as a cystic structure separate from the gallbladder.
  • Alagille syndrome: would show characteristic facies, butterfly vertebrae, and a paucity of bile ducts on biopsy.

Red flags here that mandate urgent referral: conjugated fraction >20% of total, acholic stools, and a lethargic, hypoglycaemic infant. This is a surgical emergency in the sense that the Kasai portoenterostomy has the best outcome if performed before 60 days of age.

2. Outline your immediate management and investigations in the first 24 hours, and explain why each is prioritised.

Read the worked answer

Immediate (first hour):

  1. Treat hypoglycaemia - IV 10% dextrose 2 mL/kg bolus, then continuous infusion. The glucose of 2.1 mmol/L with lethargy is a medical emergency; untreated it risks seizures and worsens the encephalopathy picture.
  2. Fluids and feeding support - the infant is 13% down and has delayed capillary refill; start maintenance fluids and involve the feeding team. Avoid over-feeding a cholestatic infant with long-chain fats; use medium-chain triglyceride formula once feeding is established.
  3. Vitamin K 1 mg IM - cholestasis causes fat-soluble vitamin malabsorption; the infant is at risk of haemorrhagic disease of the newborn and of vitamin K deficiency bleeding.
  4. Sepsis screen and empirical antibiotics - a 3-week-old with lethargy, poor perfusion, and hypoglycaemia must be covered for sepsis (blood culture, urine culture, CSF if stable, FBC, CRP, lactate) until cultures are back. Do not delay antibiotics for the bilirubin result.

Within the first 24 hours: 5. Fractionated bilirubin (already done) and repeat - confirms conjugated hyperbilirubinaemia. 6. Liver function tests, coagulation profile, albumin, ammonia, glucose, lactate, and thyroid function - to assess synthetic function and identify metabolic disease. 7. Abdominal ultrasound - look for a gallbladder (a small or absent gallbladder supports biliary atresia), a choledochal cyst, and portal vein anatomy. Ultrasound is not definitive but guides the next step. 8. Hepatitis B surface antigen, TORCH serology, and metabolic screen (including urine for reducing substances and succinylacetone) - to exclude treatable causes before labelling as biliary atresia. 9. Early referral to a paediatric hepatology/surgical centre - the window for Kasai is before 60 days; this infant is already 3 weeks old and time is the limiting factor. 10. Stool colour chart documentation - photograph the stool and record it; this is a recognised screening tool and useful for the referral letter.

What not to do: do not give phototherapy (this is conjugated hyperbilirubinaemia and phototherapy can cause bronze baby syndrome), and do not wait for a full metabolic workup before referring.

3. The parents ask why the missed 1-week visit matters and whether the baby will be 'fine'. How do you counsel them, and what determines prognosis?

Read the worked answer

Why the missed visit matters: the 1-week visit is when the health visitor or GP would have seen the pale stools and the persisting jaundice. The earlier conjugated hyperbilirubinaemia is detected, the earlier the Kasai portoenterostomy can be done. The single most important prognostic factor in biliary atresia is age at Kasai - outcomes are best when it is performed before 60 days, and success falls sharply after that. This baby is 3 weeks old, so there is still time, but the delay has narrowed the window.

What determines prognosis:

  • Age at Kasai (the dominant factor).
  • Anatomy and histology - bile duct remnant size, degree of fibrosis, and whether there is a ductal plate malformation.
  • Post-operative bile drainage - clearance of jaundice in the first 3 months after Kasai is a strong predictor of native-liver survival.
  • Complications - cholangitis, portal hypertension, and fat-soluble vitamin deficiency all affect outcome.
  • Approximately 50–60% of children will eventually need liver transplantation, and this should be discussed honestly but without removing hope; many children do well for years with a functioning Kasai.

How to say it:

  • Be honest and specific: "The pale stools and the direct bilirubin are the warning signs. We need to act in the next few days, not weeks."
  • Explain that the surgery does not cure the condition but aims to restore bile flow and buy time; some children still need a liver transplant later.
  • Explain the follow-up: regular growth and liver function monitoring, vitamin supplementation (A, D, E, K), and prompt review for fever (cholangitis).
  • Acknowledge the travel and the missed visit without blaming; ask whether there are barriers to attending appointments and offer support.
  • Give written information and a clear contact number.

Safety-netting: return immediately if the baby becomes more sleepy, feeds poorly, develops a fever, or if the stools become paler or the urine darker.